Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
New Ray Medicine International Holding Ltd. (HK:6108)
HKEX:6108
Holding HK:6108?
Track your performance easily
6108 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$0.03 - HK$0.08
Previous CloseHK$0.05
Volume784.00K
Average Volume (3M)2.89M
Market Cap
HK$80.25M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.68
Next Earnings
Mar 26, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jun 03, 2014Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares OutstandingN/A
10 Day Avg. Volume1,147,840
30 Day Avg. Volume2,891,213
Standard Deviation1.16
R-Squared0.00078
Alpha0.11
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
New Ray Medicine International Holding Ltd. News
PremiumCompany Announcements
New Ray Medicine Announces Board Structure and Leadership
PremiumCompany Announcements
New Ray Medicine Restructures Leadership Amid Executive ResignationPremiumCompany Announcements
New Ray Medicine’s H1 Revenue Plummets, Losses Narrow
PremiumCompany Announcements
New Ray Medicine Expects Notable Loss Reduction
PremiumCompany Announcements
New Ray Medicine Schedules Key Financial Meeting
PremiumCompany Announcements
New Ray Medicine Shareholders Approve Key ResolutionPremiumCompany Announcements
New Ray Medicine Allocates Funds for ExpansionPremiumCompany Announcements
New Ray Medicine Wins Land for Health Food Park6108 FAQ
What was New Ray Medicine International Holding Ltd.’s price range in the past 12 months?
New Ray Medicine International Holding Ltd. lowest stock price was HK$0.03 and its highest was HK$0.08 in the past 12 months.
What is New Ray Medicine International Holding Ltd.’s market cap?
Currently, no data Available
When is New Ray Medicine International Holding Ltd.’s upcoming earnings report date?
New Ray Medicine International Holding Ltd.’s upcoming earnings report date is Mar 26, 2025 which is in 151 days.
How were New Ray Medicine International Holding Ltd.’s earnings last quarter?
New Ray Medicine International Holding Ltd. released its earnings results on Aug 28, 2024. The company reported -HK$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.002.
Is New Ray Medicine International Holding Ltd. overvalued?
According to Wall Street analysts New Ray Medicine International Holding Ltd.’s price is currently Overvalued.
Does New Ray Medicine International Holding Ltd. pay dividends?
New Ray Medicine International Holding Ltd. pays a Notavailable dividend of HK$0.12 which represents an annual dividend yield of N/A. See more information on New Ray Medicine International Holding Ltd. dividends here
What is New Ray Medicine International Holding Ltd.’s EPS estimate?
New Ray Medicine International Holding Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does New Ray Medicine International Holding Ltd. have?
New Ray Medicine International Holding Ltd. has 1,671,846,700 shares outstanding.
What happened to New Ray Medicine International Holding Ltd.’s price movement after its last earnings report?
New Ray Medicine International Holding Ltd. reported an EPS of -HK$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of New Ray Medicine International Holding Ltd.?
Currently, no hedge funds are holding shares in HK:6108
---
New Ray Medicine International Holding Ltd. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
6.81%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-6.07%
Trailing 12-Months
Technical Analysis
Kingworld Medicines Group Ltd.
―
Human Health Holdings Ltd.
―
Hospital Corporation of China Ltd
―
COFCO Joycome Foods Limited
―
---